Form D · Other
Aqua Pharmaceuticals Holdings, Inc.
Lake Forest, IL · CIK 0001495012
Offering snapshot reported Jul 2, 2010 · SEC filing
- Reported sold
- $53.7M Offering amount: $53.7M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $150K Reported outside-investor minimum
- First sale
- Jun 23, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2010 | Initial | $53,672,333 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $1M (estimated)
- Form D file number
- 021-144371
Source: Form D, filed Jul 2, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Craig Ballaron | Director, Executive |
| Joseph Damico | Director |
| Thomas Jay Gooding | Director, Executive |
| Andrew Hochman | Director |
| David Koo | Director |
| Jack Mc Ginley | Director |
| James Utts | Director |
Issuer details
Industry: Other (See others in industry)
Address:
272 East Deerpath Road Suite 350
Lake Forest, IL, 60045
Lake Forest, IL, 60045